Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Neuren Pharmaceuticals Limited ( (AU:NEU) ) just unveiled an announcement.
Neuren Pharmaceuticals Limited has announced an update regarding its ongoing share buy-back program. As of May 9, 2025, the company has repurchased a total of 3,106,013 ordinary fully paid securities, with 73,026 bought back on the previous day. This buy-back initiative is part of Neuren’s strategy to optimize its capital structure and potentially enhance shareholder value.
More about Neuren Pharmaceuticals Limited
Neuren Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development of therapies for neurological conditions. The company is listed on the Australian Securities Exchange under the code NEU.
Average Trading Volume: 704,310
Technical Sentiment Signal: Hold
Current Market Cap: A$1.54B
Find detailed analytics on NEU stock on TipRanks’ Stock Analysis page.